Methicillin-Resistant Staphylococcus aureus
"Methicillin-Resistant Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
| Descriptor ID |
D055624
|
| MeSH Number(s) |
B03.300.390.400.800.750.100.500 B03.353.500.750.750.100.500 B03.510.100.750.750.100.500 B03.510.400.790.750.100.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methicillin-Resistant Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Methicillin-Resistant Staphylococcus aureus".
This graph shows the total number of publications written about "Methicillin-Resistant Staphylococcus aureus" by people in this website by year, and whether "Methicillin-Resistant Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 4 | 0 | 4 |
| 2011 | 4 | 2 | 6 |
| 2012 | 4 | 0 | 4 |
| 2013 | 7 | 0 | 7 |
| 2014 | 5 | 2 | 7 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 5 | 2 | 7 |
| 2018 | 6 | 2 | 8 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 3 | 0 | 3 |
| 2023 | 5 | 0 | 5 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methicillin-Resistant Staphylococcus aureus" by people in Profiles.
-
Deficiency in non-classical major histocompatibility class II-like molecule, H2-O confers protection against Staphylococcus aureus in mice. PLoS Pathog. 2024 Jun; 20(6):e1012306.
-
Assessing the Concordance of MRSA Carriage Screening With MRSA Infections. Hosp Pediatr. 2024 02 01; 14(2):84-92.
-
Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for antibiotics used for resistant gram-positive infections. Infect Control Hosp Epidemiol. 2024 Feb; 45(2):196-200.
-
Machine learning to predict risk for community-onset Staphylococcus aureus infections in children living in southeastern United States. PLoS One. 2023; 18(9):e0290375.
-
Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations. Clin Microbiol Infect. 2023 Sep; 29(9):1166-1173.
-
The Type 7b Secretion System of S. aureus and Its Role in Colonization and Systemic Infection. Infect Immun. 2023 05 16; 91(5):e0001523.
-
Space-time trends of community-onset Staphylococcus aureus infections in children: a group-based trajectory modeling approach. Ann Epidemiol. 2023 06; 82:45-53.e1.
-
Toward Optimization of a Rabbit Model of Staphylococcus aureus (USA300) Skin and Soft Tissue Infection. Microbiol Spectr. 2022 04 27; 10(2):e0271621.
-
Improving Vancomycin Stewardship in Critically Ill Children. Pediatrics. 2022 04 01; 149(4).
-
Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection. J Infect Dis. 2022 01 05; 225(1):177-185.